All terms in GO
| Label | Id | Description |
|---|---|---|
| skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration | GO_0014834 |
Any process by which the number of skeletal muscle satellite cells in a skeletal muscle is maintained during muscle regeneration. There are at least three mechanisms by which this is achieved. Skeletal muscle satellite stem cell asymmetric division ensures satellite stem cell numbers are kept constant. Symmetric division of these cells amplifies the number of skeletal muscle satellite stem cells. Some adult skeletal muscle myoblasts (descendants of activated satellite cells) can develop back into quiescent satellite cells, replenishing the overall pool of satellite cells.
|
| urinary bladder smooth muscle contraction | GO_0014832 |
A process in which force is generated within smooth muscle tissue, resulting in a change in muscle geometry. This process occurs in the urinary bladder. Force generation involves a chemo-mechanical energy conversion step that is carried out by the actin/myosin complex activity, which generates force through ATP hydrolysis. The urinary bladder is a musculomembranous sac along the urinary tract.
|
| urinary tract smooth muscle contraction | GO_0014848 |
A process in which force is generated within smooth muscle tissue, resulting in a change in muscle geometry. This process occurs in the urinary tract. Force generation involves a chemo-mechanical energy conversion step that is carried out by the actin/myosin complex activity, which generates force through ATP hydrolysis. The urinary tract consists of organs of the body that produce and discharge urine. These include the kidneys, ureters, bladder, and urethra.
|
| negative regulation of glutamate metabolic process | GO_2000212 |
Any process that stops, prevents, or reduces the frequency, rate or extent of glutamate metabolic process.
|
| regulation of glutamate metabolic process | GO_2000211 |
Any process that modulates the frequency, rate or extent of glutamate metabolic process.
|
| serine protease inhibitor complex | GO_0097180 |
A heterodimeric protein complex that contains a serine protease inhibitor and a protease; formation of the complex inhibits serine protease activity.
|
| positive regulation of glutamate metabolic process | GO_2000213 |
Any process that activates or increases the frequency, rate or extent of glutamate metabolic process.
|
| arteriole smooth muscle contraction | GO_0014830 |
A process in which force is generated within smooth muscle tissue, resulting in a change in muscle geometry. This process occurs in the arteriole. Force generation involves a chemo-mechanical energy conversion step that is carried out by the actin/myosin complex activity, which generates force through ATP hydrolysis. The arteriole is the smallest division of the artery located between the muscular arteries and the capillaries.
|
| protein C inhibitor-coagulation factor V complex | GO_0097181 |
A heterodimeric protein complex that contains protein C inhibitor (SERPINA5) and coagulation factor V (F5); formation of the complex inhibits the serine protease activity of coagulation factor V.
|
| positive regulation of anoikis | GO_2000210 |
Any process that activates or increases the frequency, rate or extent of anoikis.
|
| protein C inhibitor-coagulation factor Xa complex | GO_0097182 |
A heterodimeric protein complex that contains protein C inhibitor (SERPINA5) and coagulation factor Xa (F10); formation of the complex inhibits the serine protease activity of coagulation factor Xa.
|
| protein C inhibitor-coagulation factor XI complex | GO_0097183 |
A heterodimeric protein complex that contains protein C inhibitor (SERPINA5) and coagulation factor XI (F11); formation of the complex inhibits the serine protease activity of coagulation factor XI.
|
| response to azide | GO_0097184 |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an azide stimulus.
|
| cellular response to azide | GO_0097185 |
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an azide stimulus.
|
| cellular response to inorganic substance | GO_0071241 |
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an inorganic substance stimulus.
|
| amelogenesis | GO_0097186 |
The process whose specific outcome is the formation of tooth enamel, occurring in two stages: secretory stage and maturation stage.
|
| odontogenesis of dentin-containing tooth | GO_0042475 |
The process whose specific outcome is the progression of a dentin-containing tooth over time, from its formation to the mature structure. A dentin-containing tooth is a hard, bony organ borne on the jaw or other bone of a vertebrate, and is composed mainly of dentin, a dense calcified substance, covered by a layer of enamel.
|
| dentinogenesis | GO_0097187 |
The process whose specific outcome is the formation of dentin, the mineralized tissue that constitutes the major bulk of teeth. Dentin may be one of three types: primary dentin, secondary dentin, and tertiary dentin.
|
| dentin mineralization | GO_0097188 |
The process in which calcium salts are deposited into the calcareous tooth structure known as dentin.
|
| apoptotic body | GO_0097189 |
A vesicle containing parts of a dying cell. Apoptotic bodies can be formed during the execution phase of the apoptotic process, when the cell's cytoskeleton breaks up and causes the membrane to bulge outward. These bulges may separate from the cell, taking a portion of cytoplasm with them, to become apoptotic bodies. These are then engulfed by phagocytic cells, and their components recycled. Apoptotic bodies may range in size from 0.8 to 5um.
|